ProjectSyndicate

(AKRO) akero therapeutics daily chart review by projectsyndicate

Long
NASDAQ:AKRO   Akero Therapeutics, Inc.
long-term buy and hold from 18
target is +70% near 30.
get ready to buy dips later in q1 2020.

MY LINKS OVERVIEW
🟡 TAPLINK.CC/PRSYNDICATE
75% WINS FREE/PREMIUM SIGNALS TELEGRAM
🔴 T.ME/THESYNDICATE001
LIFETIME BUNDLE FX/CRYPTO
🟡 SYNDICATE001.CC/
FREE GOLD TRADING SIGNALS
🟡 T.ME/SYNDICATEGOLD001
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.